(Q44619785)

4 December 2017

title

Increased expression of fibroblast growth factor receptor 3 in CD34+ BCR-ABL+ cells from patients with chronic myeloid leukemia (English)

1 reference

4 December 2017

main subject

chronic myeloid leukemia

0 references

author

Petr Dvorak

1

1 reference

4 December 2017

6

1 reference

4 December 2017

Dvorakova D

2

1 reference

4 December 2017

Doubek M

3

1 reference

4 December 2017

Faitova J

4

1 reference

4 December 2017

Pacholikova J

5

1 reference

4 December 2017

Mayer J

7

1 reference

4 December 2017

publication date

1 December 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

17

1 reference

4 December 2017

issue

12

1 reference

4 December 2017

page(s)

2418-2425

1 reference

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

BCR – ABL accelerates C2-ceramide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Interferon in chronic myeloid leukemia. A workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

The pattern of gene expression in human CD34(+) stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Plasma levels of granulocyte colony-stimulating factor in patients after allogeneic bone marrow transplantation for chronic myeloid leukemia correlate with engraftment of transplanted marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Fibroblast growth factor receptor 3 induces gene expression primarily through Ras-independent signal transduction pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Interleukin-10 inhibits in vitro hematopoietic suppression and production of interferon-gamma and tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

Autonomous multi-lineage differentiation in vitro of primitive CD34+ cells from patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Changes in the expression of FGFR3 in patients with chronic myeloid leukaemia receiving transplants of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Levels of serum granulocyte colony-stimulating factor in patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403152

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403152

1 reference

4 December 2017

1 reference